• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁型肝炎的临床特征。

Clinical features of hepatitis D.

机构信息

Hepatic Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Semin Liver Dis. 2012 Aug;32(3):228-36. doi: 10.1055/s-0032-1323628. Epub 2012 Aug 29.

DOI:10.1055/s-0032-1323628
PMID:22932971
Abstract

Hepatitis D is caused by infection with hepatitis D virus (HDV), a defective RNA virus that requires the obligatory helper function of hepatitis B virus (HBV) for its in vivo transmission. Thus, HDV is acquired only by coinfection with HBV or by superinfection of an HBV carrier. The clinical outcome of hepatitis D differs according to the modality of infection. Whereas coinfection evolves to chronicity in only 2% of the cases, superinfection results in chronic infection in over 90% of the cases. HDV is a highly pathogenic virus that causes acute, often fulminant hepatitis, as well as a rapidly progressive form of chronic viral hepatitis, leading to cirrhosis in 70 to 80% of the cases. The clinical picture of HDV disease is evolving as a consequence of a significant change in the epidemiology of HDV infection, which has led to a significant decline in incidence in Western countries, mainly as a result of universal HBV vaccination programs. However, in the face of a declining prevalence in areas of old endemicity like Europe, immigration poses a threat of HDV resurgence. The interaction of HDV with other hepatitis viruses or human immunodeficiency virus is complex and may lead to different patterns in terms of virologic expression and immunologic responses. Multiple viral infections are associated with rapid progression of liver fibrosis and eventually with the development of hepatocellular carcinoma. Hepatitis D is not a vanishing disease, and continuous efforts should be made to improve its prevention and treatment.

摘要

丁型肝炎由丁型肝炎病毒(HDV)感染引起,HDV 是一种缺陷 RNA 病毒,其体内传播需要乙型肝炎病毒(HBV)的必需辅助功能。因此,HDV 仅通过与 HBV 的合并感染或 HBV 携带者的重叠感染获得。丁型肝炎的临床结局因感染方式而异。虽然合并感染仅导致 2%的病例慢性化,但重叠感染导致 90%以上的病例慢性感染。HDV 是一种高致病性病毒,可引起急性、常为暴发性肝炎,以及快速进展型慢性病毒性肝炎,导致 70%至 80%的病例发生肝硬化。HDV 疾病的临床特征因 HDV 感染的流行病学发生显著变化而不断演变,这导致西方国家的发病率显著下降,主要是由于普遍的 HBV 疫苗接种计划。然而,在像欧洲这样的旧流行地区,患病率下降的情况下,移民构成了 HDV 死灰复燃的威胁。HDV 与其他肝炎病毒或人类免疫缺陷病毒的相互作用很复杂,可能导致在病毒学表达和免疫反应方面出现不同的模式。多种病毒感染与肝纤维化的快速进展以及最终发展为肝细胞癌相关。丁型肝炎不是一种正在消失的疾病,应继续努力改善其预防和治疗。

相似文献

1
Clinical features of hepatitis D.丁型肝炎的临床特征。
Semin Liver Dis. 2012 Aug;32(3):228-36. doi: 10.1055/s-0032-1323628. Epub 2012 Aug 29.
2
[Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].[丁型肝炎病毒在肝硬化和肝细胞癌发病机制中的作用。最新进展]
Recenti Prog Med. 2010 Feb;101(2):52-6.
3
Latest discoveries on the infection and coinfection with hepatitis D virus.丁型肝炎病毒感染及合并感染的最新发现
Am Clin Lab. 2002 Jun;21(5):25-7.
4
High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.蒙古慢性肝病患者中乙型、丙型和丁型肝炎病毒双重或三重感染的高流行率。
J Med Virol. 2005 Dec;77(4):491-9. doi: 10.1002/jmv.20482.
5
Hepatitis D: A Review.肝炎 D:综述。
JAMA. 2023 Dec 26;330(24):2376-2387. doi: 10.1001/jama.2023.23242.
6
An update on HDV: virology, pathogenesis and treatment.丁型肝炎病毒最新进展:病毒学、发病机制与治疗
Antivir Ther. 2013;18(3 Pt B):541-8. doi: 10.3851/IMP2598. Epub 2013 Jun 21.
7
Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.台湾南部某医学中心的队列研究:人类免疫缺陷病毒、乙型肝炎和乙型肝炎 D 基因型 II 感染患者中肝炎事件发生率较高。
J Microbiol Immunol Infect. 2015 Feb;48(1):20-7. doi: 10.1016/j.jmii.2013.08.001. Epub 2013 Sep 21.
8
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study.随着时间的推移,急性和慢性丁型肝炎的临床转归:一项长期随访研究。
J Viral Hepat. 2011 Jun;18(6):434-42. doi: 10.1111/j.1365-2893.2010.01324.x.
9
Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection.乙型肝炎病毒相关肝细胞癌合并或不合并丁型肝炎病毒重叠感染的临床病理特征比较。
J Hepatol. 1996 Oct;25(4):439-44. doi: 10.1016/s0168-8278(96)80202-9.
10
Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.韩国慢性乙型肝炎患者中丁型肝炎病毒合并感染的流行率和临床意义。
J Med Virol. 2011 Jul;83(7):1172-7. doi: 10.1002/jmv.22095. Epub 2011 May 3.

引用本文的文献

1
Updates on Recent Advancements in Hepatitis D Virus Treatment.丁型肝炎病毒治疗的最新进展
Viruses. 2025 Aug 10;17(8):1100. doi: 10.3390/v17081100.
2
Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D.乙型、丙型和丁型肝炎的发病机制、预防及治疗进展
Virol J. 2025 Aug 11;22(1):274. doi: 10.1186/s12985-025-02907-3.
3
Clinical impact of hepatitis delta virus coinfection on liver fibrosis in hepatitis B patients: a population-based study.丁型肝炎病毒合并感染对乙型肝炎患者肝纤维化的临床影响:一项基于人群的研究。
Virol J. 2025 Aug 9;22(1):273. doi: 10.1186/s12985-025-02908-2.
4
Epidemiology of hepatitis delta virus (HDV) infection and comparison of clinical characteristics and disease progression among patients with HDV vs. hepatitis B mono-infection: real-world data from a large healthcare insurer-provider in Israel.丁型肝炎病毒(HDV)感染的流行病学以及HDV感染患者与乙型肝炎单一感染患者的临床特征和疾病进展比较:来自以色列一家大型医疗保险公司-医疗机构的真实世界数据。
Virol J. 2025 Aug 6;22(1):271. doi: 10.1186/s12985-025-02897-2.
5
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm.丁型肝炎病毒感染对本地人和移民的医学影响:意大利范例
Liver Int. 2025 Sep;45(9):e70242. doi: 10.1111/liv.70242.
6
IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures.在丁型肝炎病毒感染的肝细胞培养物中,干扰素-β 的产生促进代谢重塑并抵御氧化应激。
Cell Death Dis. 2025 Jul 18;16(1):534. doi: 10.1038/s41419-025-07838-z.
7
Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS).探索慢性丁型肝炎(CHD)患者的体验,以及评估《肝炎生活质量问卷》(HQLQv2)和《疲劳严重程度量表》(FSS)的内容效度。
J Patient Rep Outcomes. 2025 Jul 7;9(1):84. doi: 10.1186/s41687-025-00903-3.
8
Hope on the horizon: Emerging therapies for hepatitis D.曙光在前:丁型肝炎的新兴疗法
World J Hepatol. 2025 Jun 27;17(6):107963. doi: 10.4254/wjh.v17.i6.107963.
9
A comprehensive review of diagnostic approaches for hepatitis D.丁型肝炎诊断方法的全面综述。
Front Mol Biosci. 2025 May 21;12:1598784. doi: 10.3389/fmolb.2025.1598784. eCollection 2025.
10
A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D.一种用于丁型肝炎血清学诊断的通用即时检测免疫层析试验。
J Clin Microbiol. 2025 May 14;63(5):e0199924. doi: 10.1128/jcm.01999-24. Epub 2025 Apr 11.